Sarofim Fayez’s Bristol-Myers Squibb BMY Stock Holding History

Sarofim Fayez’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$758K	Buy	+16,374	New	+$719K	﹤0.01%	150

Other funds holding BMY

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Sarofim Fayez's BMY Position: Q3 2013 in Review

Sarofim Fayez opened a new position in Bristol-Myers Squibb (BMY) in Q3 2013: 16,374 shares worth $758K. The stake represents ﹤0.01% of the portfolio and ranks #150 among its holdings.

1,188 funds tracked by Wall St. Rank hold BMY as of Q3 2013.

Sarofim Fayez held 16,374 shares of Bristol-Myers Squibb worth $758K as of Q3 2013.
Bristol-Myers Squibb was a new Sarofim Fayez position in Q3 2013.
Bristol-Myers Squibb made up ﹤0.01% of Sarofim Fayez's portfolio in Q3 2013, its #150 holding.
1,188 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.